Single-atom nanozymes towards central nervous system diseases

查看全文 作　　者：Weichen [1]Wei

机构地区：[1]Department of Nanoengineering,University of California San Diego,La Jolla 92093,USA

出　　处：《Nano Research》索引2023年第16卷第4期,共19页

基　　金：supported by Jacobs Fellowship from the University of California San Diego. 摘　　要：Nanozymes have a similar catalytic mechanism to natural enzymes,with excellent performance,facile synthesis,and better stability.Single-atom nanozymes are developed based on single-atom catalysts due to their advantages in coordination structure and electronic configuration,making them highly enzymatic-like biomimetic catalysts.Central nervous system(CNS)diseases have become one of the biggest killers of human health because they are difficult to diagnose and treat,expensive,and result in serious illness.Single-atom nanozymes have been widely used for biomedical applications,especially in oxidative-stressinduced diseases and most CNS diseases which are closely related to oxidative stress.Therefore,single-atom nanozymes show promising application prospects for the treatment of CNS diseases.In addition,due to the outstanding material properties and sensitivity of single-atom nanozymes,they also exhibit great advantages in detecting various CNS disease markers for diagnosis. 关键词：single-atom nanozymes single-atom catalysis central nervous system diseases enzyme-like catalysts reactive oxygen species

相关文献

参考文献（186）
引证文献（2）
耦合文献（0）

参考文献(186)

引证文献(2)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Single-atom nanozymes towards central nervous system diseases

参考文献(186)

引证文献(2)

用户提示